Healthcare — Oncology Pipeline Breakthroughs Dominate: Revolution Medicines Reports Doubled Survival in Pancreatic Cancer; Allogene CAR-T Clears Residual Lymphoma; Hospitals Deploy AI Chatbots to Recapture Patient Engagement

Healthcare · 2026-04-13

TODAY'S SIGNAL — April 13, 2026 was a landmark day for oncology pipelines and a signal day for digital health strategy. Revolution Medicines reported that its oral pancreatic cancer therapy doubled median survival versus chemotherapy — a result the company called "unprecedented" in a disease with notoriously poor outcomes. Simultaneously, Allogene Therapeutics presented data showing its…